A widely used blood pressure drug is being pulled from circulation after federal regulators determined that tens of thousands of bottles failed to meet basic safety standards. The Food and Drug Administration has initiated a recall of more than 11,000 bottles of Chlorthalidone tablets, raising concerns among patients who rely on the medication to manage hypertension.
The chlorthalidone recall covers 11,460 bottles of the 25-milligram formulation and affects products distributed across the United States.
What Triggered The Chlorthalidone Recall?
The problem is not with the chemical itself but with how the tablet behaves once swallowed. According to the FDA, the affected batches failed dissolution testing, meaning the tablets do not break down at the rate required to deliver a consistent, effective dose.
This matters more than it might sound. When a tablet dissolves too slowly or unevenly, the active ingredient may not be absorbed into the bloodstream the way it should be. For a blood pressure medication, that can translate to doses that are weaker than intended, or in some cases unpredictably absorbed.
For patients who are counting on a specific drug to keep their blood pressure within a safe range, inconsistent absorption is not a minor inconvenience. It can leave them unknowingly under-medicated.
The FDA has classified this as a Class II recall. That designation is used when a product may cause temporary or medically reversible health consequences, or where the probability of serious harm is considered low but not negligible. It sits in the middle of the agency’s three-tier system and signals a meaningful concern without the immediate danger associated with a Class I action.
Which Bottles Are Affected?
The recall applies to two bottle sizes: the 100-tablet bottle and the 1,000-tablet bottle. Both sizes share an expiration date of April 2027, which means they are still within date and could easily be sitting on pharmacy shelves or in patients’ medicine cabinets right now.
The specific lot numbers to look for are RISA24001 for the 100-tablet bottle and RISB24002 for the 1,000-tablet bottle. Anyone who has Chlorthalidone tablets at home should check those numbers carefully before taking another dose.
The manufacturer is Inventia Healthcare Limited, an India-based pharmaceutical company. The product was distributed in the United States by Risiong Pharma Holdings, Inc., headquartered in East Brunswick, New Jersey.
Who Takes Chlorthalidone & Why Does This Recall Matters?
Chlorthalidone belongs to a class of drugs called thiazide-like diuretics, sometimes referred to as water pills. It works by helping the kidneys remove excess sodium and fluid from the body, which reduces blood volume and in turn lowers blood pressure. It has been used for decades and is considered one of the more cost-effective first-line treatments for hypertension.
Because it is affordable and well-established, it tends to be prescribed broadly, including to older adults and patients who are managing multiple conditions simultaneously. That demographic is also among the most vulnerable when a medication underperforms.
Someone in their sixties or seventies taking Chlorthalidone for high blood pressure may have few obvious symptoms if the drug is not working as expected. Blood pressure problems rarely come with warning signs until they become serious.
That is part of what makes this chlorthalidone recall worth paying attention to even though it falls into the lower-risk Class II category. The absence of immediate danger does not mean the situation is without consequence.
What Patients Should Do Right Now?
If you are currently taking Chlorthalidone 25 mg tablets, the first step is to locate the bottle and check the lot number and expiration date. If your bottle matches either of the recalled batches listed above, do not simply discard it and assume the problem is resolved.
The FDA advises returning recalled products to the point of purchase. Most pharmacies and retail outlets that sell prescription medications have established procedures for handling recalls, and they are typically required to offer a refund or replacement. Contact your pharmacy directly and let them know the bottle matches a recalled lot number.
Do not stop taking your blood pressure medication without talking to your doctor first. Even if your current supply is affected, abruptly discontinuing a hypertension drug can cause blood pressure to spike. Your prescribing physician or pharmacist can guide you on next steps, which may include switching to a different lot, a different manufacturer, or an alternative medication while the situation is sorted out.
If you have been taking pills from one of the recalled lots and have noticed your blood pressure readings trending higher than usual, bring that to your doctor’s attention. It may or may not be connected, but it is worth discussing.
The Bigger Picture On Pharmaceutical Recalls
Recalls like this one are more common than many people realize. The FDA monitors pharmaceutical manufacturing facilities and tests products on an ongoing basis, and dissolution failures are among the more frequently cited reasons for pulling a drug from distribution. The issue often stems from manufacturing inconsistencies rather than problems with the drug formula itself.
What patients can take from this is a practical habit: hold onto your medication bottles long enough to check lot numbers when a recall is announced, and pay attention to FDA recall notices. The agency maintains a publicly accessible database of all active recalls at accessdata.fda.gov, which is updated regularly.
For now, anyone with questions about the chlorthalidone recall can also reach out to Risiong Pharma Holdings directly or speak with their pharmacist, who should already be aware of the recall and prepared to help with next steps.
